Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation
NCT ID: NCT02911129
Last Updated: 2025-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2016-11-04
2025-02-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After a stroke, the balance between the two halves of the brain can be lost. This may cause people to lose the ability to perceive a side of space. This is called neglect. Having people wear prism glasses (called PA) can reduce neglect symptoms. Researchers want to find out more about how PA, and whether it restores the balance in the brain.
Objective:
To learn how prism adaption temporarily changes vision and connections in the brain.
Eligibility:
People ages 18 75 with brain damage of the right side of the brain from a stroke or other cause, leading to neglect.
Healthy volunteers ages 18 75.
Design:
Participants will have 1 3 visits.
Participants will be screened with a neurological exam. They may also have:
Tests of thinking and vision
Tests to see which eye and hand they prefer
A pregnancy test
All participants will:
Answer questions about their personality, style of thinking, and beliefs.
Do simple tasks on paper or computer
Have magnetic resonance imaging. They will lie on a table that can slide in and out of a cylinder in a strong magnetic field. Participants will lie still or do computer tasks in the scanner.
Participants may also have:
Transcranial magnetic stimulation. A brief electrical current passes through a wire coil on the scalp. This creates a magnetic pulse that affects brain activity. Participants may be asked to tense certain muscles or perform simple actions or tasks.
PA. They will sit in front of a board and point to a dot on it while they wear prism glasses that shift vision to the left or right....
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potentiation of the Effects of Prismatic Adaptation by Transcranial Direct Current Stimulation (tDCS) : Evaluation of Functional Interest in Negligence Rehabilitation
NCT02213640
Prism Adaptation Therapy for Spatial Neglect
NCT00989430
Prismatic Lenses and tDCS in Neglect
NCT05842551
Feasibility of Using Prism Adaptation to Treat Spatial Neglect and Motor Function in Stroke
NCT02419222
Virtual Prism Adaptation Therapy on Hemispatial Neglect
NCT03771872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ability to efficiently select information from the environment relies on a balanced interaction between the right and left hemispheres. Hemispatial neglect, most frequently following damage to the right hemisphere, has been hypothesized to result from the breakdown of this interhemispheric balance. There is evidence from transcranial stimulation studies that the breakdown of this interhemispheric balance is reflected in fronto-parietal connectivity. The primary goal of this study is to test whether altering the balance between the left and right hemispheres, with repetitive transcranial magnetic stimulation (rTMS) or prism adaptation (PA), will affect functional connectivity measured with functional magnetic resonance imaging (fMRI). We will also explore the relationship between the changes in functional connectivity and behavioral performances.
STUDY POPULATION: Healthy adult volunteers and patients with neglect after a right hemisphere damage.
DESIGN: The study contains three experiments. Experiment 1 is designed to investigate the mechanism of the changes induced by PA in both resting state functional connectivity in neglect patients and healthy volunteers (a two-arm parallel study). Experiment 2 is designed to investigate the mechanism of the changes in resting state functional connectivity induced by lPA, rPA, nPA in healthy volunteers with right dominant eyes and lPA in healthy volunteer with left dominant eye (a four-arm parallel study). Experiment 3 is designed to see if inhibitory rTMS over the right posterior parietal cortex (PPC) can influence functional connectivity and visuospatial bias in healthy volunteers (a crossover study).
OUTCOME MEASURES: For all three experiments the primary outcome measure is the change (or difference) in fronto-parietal resting state connectivity between post and pre PA or rTMS procedure. The secondary outcome measures are the changes in visual field representation and in visuo-motor and cognitive behavior accompanying these manipulations.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Volunteer
Inclusion Criteria for Healthy Volunteers/Age-matched Controls
No interventions assigned to this group
Patients
Patients with neglect after a right hemisphere brain lesion
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Experiment 2 requires 63 healthy volunteers having right dominant eye and 21 volunteers having left dominant eye. Therefore, healthy volunteers with left dominant eye will be recruited until the necessary number is reached. We estimate we will have to screen 150
healthy volunteers. Participants for whom the study was not completed due to technical problems and who did not undergo prism adaptation or TMS will be retested and data from the incomplete session will not be analyzed.
Experiment 1
* Age 18-75 (inclusive; we will try to match this to the stroke group)
* Montreal Cognitive Assessment score greater than or equal to 26
* Absence of neglect at time of testing (Diller test score less than or equal to 2)
Experiments 2 and 3
* Right-handedness
* Age 18-35 (inclusive)
* Twelve or more years of education
* Are able to see a dot of size 0.2 inches at a distance of 22.5 inches without glasses or with contact lenses (only for Experiment 2)
Experiment 1
* Age 18-75 (inclusive)
* Montreal Cognitive Assessment score greater than or equal to 26
* A right hemisphere stroke or other focal, non-progressive, brain lesion resulting in neglect
* Minimum of 30 days from lesion onset to testing
* Evidence of neglect at time of testing (Diller test score greater than or equal to 5)
Exclusion Criteria
* History of seizure (for Experiment 3)
* Inability to give informed consent
* Concurrent use of sedating medications
* Trained to write in other than left to right direction
* Ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, or ocular foreign body
* Implanted cardiac pacemaker or auto-defibrillator or pump
* Non-removable body piercing
* Claustrophobia
* Inability to lie supine for 1.5 hour
* Pregnancy
* Members of the NINDS Behavioral Neurology Unit (BNU)
* Significant illness affecting the central nervous system, other than right hemisphere lesion causing neglect in patients
* Inability to give informed consent
* Concurrent use of sedating medications
* Ferromagnetic metal in the cranial cavity or eye, e.g. aneurysm clip, implanted neural stimulator, cochlear implant, or ocular foreign body
* Implanted cardiac pacemaker or auto-defibrillator or pump
* Non-removable body piercing
* Claustrophobia
* Inability to lie supine for 1.5 hour
* Pregnancy
* Members of the NINDS Behavioral Neurology Unit (BNU)
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric M Wassermann, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-N-0170
Identifier Type: -
Identifier Source: secondary_id
160170
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.